Algorae Pharmaceuticals Limited has released a press release.
Peter Mac Partners with Algorae on AI Drug Targets
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Algorae Receives A$451,359 R&D Cash Rebate from ATO
- Half Yearly Report Announcement and Appendix 4D
- Significant Cardioprotection Qualities in AI-168 Studies
- 24 New AI-Generated Drug Targets
- AlgoraeOS Artificial Intelligence Platform Launched
Later from Algorae Pharmaceuticals
- Algorae Receives A$318,771 R&D Cash Rebate from ATO
- Annual Report and Appendix 4E
- Algorae Signs Exclusive License Agreement with Sakar
- Algorae Signs Binding Term Sheet with Cadila Pharmaceuticals
- AlgoraeOS Version 2 AI Platform Launched
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals